368 related articles for article (PubMed ID: 12357145)
1. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?
Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G
Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145
[TBL] [Abstract][Full Text] [Related]
2. The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine.
Lötsch J; Skarke C; Grösch S; Darimont J; Schmidt H; Geisslinger G
Pharmacogenetics; 2002 Jan; 12(1):3-9. PubMed ID: 11773859
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.
Romberg RR; Olofsen E; Bijl H; Taschner PE; Teppema LJ; Sarton EY; van Kleef JW; Dahan A
Anesthesiology; 2005 Mar; 102(3):522-30. PubMed ID: 15731588
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
[TBL] [Abstract][Full Text] [Related]
5. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
6. Human opioid μ-receptor A118G polymorphism may protect against central pruritus by epidural morphine for post-cesarean analgesia.
Tsai FF; Fan SZ; Yang YM; Chien KL; Su YN; Chen LK
Acta Anaesthesiol Scand; 2010 Nov; 54(10):1265-9. PubMed ID: 21039348
[TBL] [Abstract][Full Text] [Related]
7. Morphine metabolism, transport and brain disposition.
De Gregori S; De Gregori M; Ranzani GN; Allegri M; Minella C; Regazzi M
Metab Brain Dis; 2012 Mar; 27(1):1-5. PubMed ID: 22193538
[TBL] [Abstract][Full Text] [Related]
8. Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers.
Lötsch J; Geisslinger G
Pharmacogenomics J; 2006; 6(3):200-10. PubMed ID: 16415919
[TBL] [Abstract][Full Text] [Related]
9. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
10. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
[TBL] [Abstract][Full Text] [Related]
11. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans.
Mogil JS; Ritchie J; Smith SB; Strasburg K; Kaplan L; Wallace MR; Romberg RR; Bijl H; Sarton EY; Fillingim RB; Dahan A
J Med Genet; 2005 Jul; 42(7):583-7. PubMed ID: 15994880
[TBL] [Abstract][Full Text] [Related]
12. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy.
Chou WY; Wang CH; Liu PH; Liu CC; Tseng CC; Jawan B
Anesthesiology; 2006 Aug; 105(2):334-7. PubMed ID: 16871067
[TBL] [Abstract][Full Text] [Related]
13. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty.
Chou WY; Yang LC; Lu HF; Ko JY; Wang CH; Lin SH; Lee TH; Concejero A; Hsu CJ
Acta Anaesthesiol Scand; 2006 Aug; 50(7):787-92. PubMed ID: 16879459
[TBL] [Abstract][Full Text] [Related]
14. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief.
Campa D; Gioia A; Tomei A; Poli P; Barale R
Clin Pharmacol Ther; 2008 Apr; 83(4):559-66. PubMed ID: 17898703
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test.
Lötsch J; Tegeder I; Angst MS; Geisslinger G
Life Sci; 2000 May; 66(24):2393-403. PubMed ID: 10864101
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain.
De Gregori M; Garbin G; De Gregori S; Minella CE; Bugada D; Lisa A; Govoni S; Regazzi M; Allegri M; Ranzani GN
Eur J Clin Pharmacol; 2013 Sep; 69(9):1651-8. PubMed ID: 23686330
[TBL] [Abstract][Full Text] [Related]
18. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
[TBL] [Abstract][Full Text] [Related]
19. Morphine 6beta glucuronide: fortuitous morphine metabolite or preferred peripheral regulatory opiate?
Mantione KJ; Goumon Y; Esch T; Stefano GB
Med Sci Monit; 2005 May; 11(5):MS43-46. PubMed ID: 15874899
[TBL] [Abstract][Full Text] [Related]
20. Morphine-6-glucuronide: potency and safety compared with morphine.
van Dorp EL; Morariu A; Dahan A
Expert Opin Pharmacother; 2008 Aug; 9(11):1955-61. PubMed ID: 18627332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]